ArticleFrontiers in oncology2025

Real-world treatment and retreatment patterns and outcomes in patients with advanced or metastatic non-small cell lung cancer following nivolumab monotherapy in second line or later in France: an I-O Optimise analysis.

Grégoire Justeau et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.